Real-world treatment and outcomes of ALK-positive metastatic non–small cell lung cancer in a southeast Asian country

• Main Authors: Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H, Tho, Lye Mun, Muhamad Nor, Ibtisam, Lim, Bee Chiu Lim, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Kuan Tan, Justin Yu, Zainal Abidin, Muhammad Adil
• Format: Article
• Language: English; English
• Published: Dove Medical Press 2023
• Subjects: RC270 Neoplasms. Tumors. Oncology-Cancer and Other Malignant Neoplasms-Therapeutics
• Online Access: http://irep.iium.edu.my/103209/2/103209_Real-world%20treatment%20and%20outcomes.pdf; http://irep.iium.edu.my/103209/8/103209_Real-world%20treatment%20and%20outcomes_Scopus.pdf; http://irep.iium.edu.my/103209/; https://www.dovepress.com/articles.php?article_id=80981#

Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non–small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide...